Literature DB >> 11334363

Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor (MIF).

P C Joshi1, G V Poole, V Sachdev, X Zhou, Q Jones.   

Abstract

Macrophage migration inhibitory factor (MIF) is a pituitary "stress" hormone that plays a critical role in the host immune response. The aims of the study were to determine whether MIF was detectable in the circulation of trauma patients, to assess whether MIF levels were associated with injury severity, days post injury, infection, and to examine concentrations of other pro-inflammatory cytokines in circulation. We collected plasma samples from 35 trauma (multiple injury) patients and 18 healthy controls. Concentrations of MIF, TNF-alpha, IL-1beta, and IL-6 were measured by ELISA. Average MIF concentration in plasma of trauma patients was 14 fold higher than that of healthy controls (19,439+/-2,615 pg/ml in trauma vs 1,337+/-286 pg/ml in control; p=0.0002). There was no correlation between MIF values and injury severity score or days post injury. Average level of IL-6 in trauma patients was 587+/-85 pg/ml but was not correlated with MIF concentration. TNF-alpha and IL-1beta were not detectable in trauma patients or healthy controls. Higher MIF levels were associated with positive cultures (blood, urine, sputum, wound). These data suggest that MIF may be a possible indicator of infection in trauma patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11334363

Source DB:  PubMed          Journal:  Res Commun Mol Pathol Pharmacol        ISSN: 1078-0297


  6 in total

1.  Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.

Authors:  Sakhawat H Rahman; Krishna V Menon; John H M Holmfield; Michael J McMahon; J Pierre Guillou
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

2.  Trauma: the role of the innate immune system.

Authors:  F Hietbrink; L Koenderman; Gt Rijkers; Lph Leenen
Journal:  World J Emerg Surg       Date:  2006-05-20       Impact factor: 5.469

3.  Macrophage migration inhibitory factor as a diagnostic and predictive biomarker in sepsis: meta-analysis of clinical trials.

Authors:  Janos Toldi; David Nemeth; Peter Hegyi; Zsolt Molnar; Margit Solymar; Nelli Farkas; Hussain Alizadeh; Zoltan Rumbus; Eszter Pakai; Andras Garami
Journal:  Sci Rep       Date:  2021-04-13       Impact factor: 4.379

4.  Inhibition of Macrophage Migration Inhibitory Factor Activity Attenuates Haemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats.

Authors:  Nikita M Patel; Noriaki Yamada; Filipe R M B Oliveira; Lara Stiehler; Elisabeth Zechendorf; Daniel Hinkelmann; Sandra Kraemer; Christian Stoppe; Massimo Collino; Debora Collotta; Gustavo Ferreira Alves; Hanna Pillmann Ramos; Regina Sordi; Ingo Marzi; Borna Relja; Gernot Marx; Lukas Martin; Christoph Thiemermann
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

5.  Improvement of prognostic performance in severely injured patients by integrated clinico-transcriptomics: a translational approach.

Authors:  Daniel Rittirsch; Veit Schoenborn; Sandro Lindig; Elisabeth Wanner; Kai Sprengel; Sebastian Günkel; Barbara Schaarschmidt; Sonja Märsmann; Hans-Peter Simmen; Paolo Cinelli; Michael Bauer; Ralf A Claus; Guido A Wanner
Journal:  Crit Care       Date:  2015-11-26       Impact factor: 9.097

Review 6.  Macrophage migration inhibitory factor: a regulator of innate immunity.

Authors:  Thierry Calandra; Thierry Roger
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.